These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1008865)

  • 1. Guanidino compounds in the sera of uremic patients and in the sera and brain of experimental uremic rabbits.
    Matsumoto M; Kishikawa H; Mori A
    Biochem Med; 1976 Aug; 16(1):1-8. PubMed ID: 1008865
    [No Abstract]   [Full Text] [Related]  

  • 2. Guanidino compound levels in brain regions of non-dialyzed uremic patients.
    De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C
    Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
    Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion-exchange chromatographic separation and fluorometric detection of guanidino compounds in physiologic fluids.
    Yamamoto Y; Manji T; Saito A; Maeda K; Ohta K
    J Chromatogr; 1979 Mar; 162(3):327-40. PubMed ID: 43330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of guanidino compounds by anion-exchange chromatography and amperometric detection.
    Ding WD; Veening H; Van Effen RM
    J Chromatogr; 1990 Apr; 526(2):355-66. PubMed ID: 2361978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous guanidino compounds as uremic neurotoxins.
    De Deyn PP; D'Hooge R; Van Bogaert PP; Marescau B
    Kidney Int Suppl; 2001 Feb; 78():S77-83. PubMed ID: 11168988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of methylguanidine in serum and urine from normal and uremic subjects.
    Menichini GC; Gonella M; Barsotti G; Giovannetti S
    Experientia; 1971 Oct; 27(10):1157-8. PubMed ID: 5127860
    [No Abstract]   [Full Text] [Related]  

  • 8. Ontogenetic differences in convulsive action and cerebral uptake of uremic guanidino compounds in juvenile mice.
    D'Hooge R; Pei YQ; Marescau B; De Deyn PP
    Neurochem Int; 1994 Mar; 24(3):215-20. PubMed ID: 8025530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1844-5. PubMed ID: 9845964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
    D'Hooge R; Pei YQ; Marescau B; De Deyn PP
    J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic system for the assay of guanidino compounds to assess uremic status.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T; Watanabe M
    Biol Pharm Bull; 2000 Sep; 23(9):1015-20. PubMed ID: 10993196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of guanidino compounds in serum and brain of mouse, rat, rabbit, and man.
    Marescau B; De Deyn P; Wiechert P; Van Gorp L; Lowenthal A
    J Neurochem; 1986 Mar; 46(3):717-20. PubMed ID: 3950603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
    Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis].
    Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P
    J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative studies of plasma and urine levels between uremic peak 2a and guanidino compounds].
    Koide K; Toyama J; Inoue N; Koshikawa S; Akizawa T; Takahashi K; Hidaka S; Yamane Y; Nakao M; Ono S
    Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):485-92. PubMed ID: 3656706
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylguanidine in uremia.
    Giovannetti S; Balestri PL; Barsotti G
    Arch Intern Med; 1973 May; 131(5):709-13. PubMed ID: 4701382
    [No Abstract]   [Full Text] [Related]  

  • 18. Uremic concentrations of guanidino compounds inhibit neutrophil superoxide production.
    Hirayama A; Noronha-Dutra AA; Gordge MP; Neild GH; Hothersall JS
    Kidney Int Suppl; 2001 Feb; 78():S89-92. PubMed ID: 11168990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new automated analytical method for gaunidino compounds and their cerebrospinal fluid levels in uremia.
    Yamamoto Y; Saito A; Manji T; Nishi H; Ito K; Maeda K; Ohta K; Kobayashi K
    Trans Am Soc Artif Intern Organs; 1978; 24():61-8. PubMed ID: 716068
    [No Abstract]   [Full Text] [Related]  

  • 20. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
    Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
    Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.